Structure-Based Discovery and Optimization of Benzo[<i>d</i>]isoxazole Derivatives as Potent and Selective BET Inhibitors for Potential Treatment of Castration-Resistant Prostate Cancer (CRPC)

Maofeng Zhang(Guangzhou Institutes of Biomedicine and Health), Yong Xu(Guangzhou Institutes of Biomedicine and Health), Baijun Dong(Renji Hospital), Yulai Zhou(Central South University), Qiuping Xiang(Guangzhou Institutes of Biomedicine and Health), Donghai Wu(University of Florida), Xishan Wu(Guangzhou Institutes of Biomedicine and Health), Chenchang Li(Jilin University), Lingjiao Zou(Guangzhou Institutes of Biomedicine and Health), Ke Ding(China Pharmaceutical University), Hongwu Chen(Northwest A&F University), Chao Wang(Guangzhou Institutes of Biomedicine and Health), Wei Xue(National Sun Yat-sen University), Yan Zhang(Chinese Academy of Sciences), Chun Wu(Guangzhou Institutes of Biomedicine and Health), Xiaoqian Xue(Guangzhou Institutes of Biomedicine and Health), Junjian Wang(Sun Yat-sen University), Cheng Zhang(Mayo Clinic), Ming Song(Qilu University of Technology)
Journal of Medicinal Chemistry
March 22, 2018
Cited by 63


Related Papers